Yes, the problem is man made, but not only due to unofficial access to antibiotics. I suspect that's not even a major factor, but correct me if I've missed som

Yes, the problem is man made, but not only due to unofficial access to antibiotics. I suspect that's not even a major factor, but correct me if I've missed something. As discussed: TB currently takes a long time to fully treat. A lot of patients can't afford a full course of the recommended combination of drugs. Even if they can, and are getting their drugs from official channels, they need to be monitored regularly (sometimes daily) to ensure proper treatment. The resources to do this monitoring simply don't exist in India (and many other countries). Thus, even if you could stop all unofficial access to antibiotics (impossible in practice), there is simply not enough funding to ensure every patient is properly treated. This is why a shorter regimen is a key breakthrough. It makes proper treatment much more accessible (the big issue), while also reducing the discipline needed to complete a course (a small bonus).